Best practices in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer

March 21, 2025 00:26:05
Best practices in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer
COR2ED - Oncology Medical Conversation
Best practices in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer

Mar 21 2025 | 00:26:05

/

Show Notes

This podcast explores the best practices in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer.  

Dr Rena Callahan and Dr Roberto Salgado discuss key biomarkers, testing methods, and clinical decision-making, offering expert insights on how to optimise precision medicine.  

Topics include liquid vs. tumour biopsy, single gene vs. broad panel testing, and regional differences in testing practices.  

Tune in for a practical, expert-led discussion on how molecular testing can guide personalised treatment and improve patient outcomes. 

 

Key clinical takeaways: 

 

You can also watch a video of the experts in conversation and download the accompanying transcript on our website: https://cor2ed.com/precision-oncology-connect/programmes/molecular-testing-targeted-therapy-metastatic-breast-cancer/?media=0

Or watch on YouTube: https://www.youtube.com/watch?v=CTnXmh1oDwQ

Follow us on social media: 

LinkedIn: https://www.linkedin.com/company/ntrk-connect/  

X: https://x.com/PresOnc_Connect  

This content is intended for healthcare professionals only. 

The medical experts in this podcast are expressing their own views and not those of COR2ED, Supporters or their institution.  This podcast is supported by an Independent Education Grant from Thermo Fisher Scientific. 

This podcast is developed by cor2ed.com 

Published March 2025 

Subscribe to this channel to stay up to date with new Independent Education programmes as they’re released. 

Other Episodes

Episode

November 21, 2024 00:23:21
Episode Cover

HCC podcast series part 1: The use of IO in unresectable HCC

In the first of this 4-part podcast series on HCC, Dr Rachna Shroff and Oncology Brothers Drs Rohit and Rahul Gosain explore the use...

Listen

Episode

December 06, 2023 00:20:43
Episode Cover

Multiple Myeloma: Choosing the best treatment regimen in newly diagnosed patients - Part 1

In this medical education podcast series, myeloma experts Dr. Joshua Richter (Assistant Professor of Medicine and Director of Myeloma at the Tisch Cancer Institute...

Listen

Episode

December 06, 2023 00:21:52
Episode Cover

Thyroid cancer: Optimising VEGFR-TKIs (MKIs) in differentiated thyroid cancer

Dr. Jaume Capdevila, a Medical Oncologist at Vall d’Hebron University Hospital in Barcelona, Spain, and Dr. Rachel van Leeuwaarde, an Endocrinologist from the University...

Listen